Despite the dire headlines, venture capitalists are still investing in medtech start-ups, although the deals are becoming fewer and later stage. Start-ups looking for funding have to be more creative and look beyond traditional sources of funding, according to a discussion by six European VCs speaking at the IN3 meeting in Dublin in April 2013.